European Primary Care Cardiovascular Society

Statin-intolerant patients and lipid-lowering therapies

Experts in dialogue - LDL-c goal attainment in high risk patients

15' education - June 1, 2021 - Prof. Maciej Banach (Lodz, Poland) and prof. Ulrich Laufs, MD, PhD (Leipzig, Germany)

Educational information

The series 'Experts in dialogue - LDL-c goal attainment in high risk patients' has been developed in response to an Expert Meeting, in which the current situation on LDL-c guideline implementation, barriers of implementation and solutions to improve the proportion of patients achieving their target goals were discussed.

Other topics covered in this series

This educational video is part of a series with different expert discussing the issues and challenges on LDL-c goal attainment in high CV risk patients:

- The proven case for LDL-c lowering Prof. Kausik Ray, London, UK and prof. John Kastelein Amsterdam, The Netherlands

- The gap between LDL-c guideline goals and current practice: how well are we doing? Prof. François Mach, Geneva, Switzerland and prof. Erik Stroes, Amsterdam, The Netherlands

- What are current challenges and barriers in achieving LDL-c goals? Prof. Kausik Ray, London, UK and prof. Lale Tokgözoğlu, Ankara, Turkey


Prof. Ulrich Laufs, MD, PhD, is professor of cardiology at the University of Leipzig Medical Center in Germany.

Prof. Maciej Banach, MD, PhD – is a Full Professor of Cardiology at the Medical University of Lodz (MUL), Lodz, Poland.


The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of EPCCS.

Funding for the Expert Meeting was provided by unrestricted educational grants received from Amgen and Sanofi. The sponsors did not attend and influence the Expert Meeting and the video recording.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: